Trish Costello
Founder & CEOPortfoliaMs. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.
Jennifer Schneiders
President Diagnostic SolutionsHologicHadine Joffee
MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender BiologyBrigham and Women’s Hospital & Harvard Medical SchoolShefali Goyal MS, MSc
Vice President, Head of Global RA Strategy and US Regulatory AffairsOrganonMonica Garcia
Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,FDANichole YoungLin
MD, MBA, Women’s Health Clinical LeadGooglePatricia Obermaier
Chief Growth Officer, Global Health and Life SciencesMicrosoftAsima Ahmad
Co-Founder & Chief Medical OfficerCarrot FertilityDr. Neel Shah
Chief Medical OfficerMaven ClinicCarolee Lee
Founder & CEOWHAM (Women's Health Access Matters)Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.
Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.
Elizabeth Cherot
MD, MBA, Chief Medical OfficerMarch of DimesJason Roberts
Gynecological and Surgical Devices, CDRH,FDAMichael Annichine
CEOMagee-Womens Research InstituteAlice Zheng, MD, MBA, MPH
PrincipalRH CapitalDiana Torgersen
Executive Director, External Innovation & Emerging ScienceOrganonLisa Suennen
Managing Partner, AHA VenturesAmerican Heart AssociationDaniel Johnston
Chief, Contraception Research BranchEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentLaura Clark-Kelly
Senior Director of Value & ReimbursementHarmony BiosciencesGreg Singleton
Chief Artificial Intelligence OfficerUS Department of Health & Human ServicesPiraye Beim
Founder & CEOCelmatixEverett Handford
MBA, Regional Director, New England US Department of HealthHuman ServicesNatalie Buford-Young
CEOSpringboard EnterprisesNada Hanafi MSc, MPH
Founder & Manager, MedTech Strategy Advisors LLC; Co-FounderMedTech ColorSusan Nicholson
MD, FIDSA, Board MemberASPIVIXRoslyn Holliday Moore
Deputy Director for ProgramsOffice of Behavioral Equity, US Department of Health and Human ServicesJasmi Shah
Managing DirectorCigna VenturesJacqueline Oliveira-Cella
FounderwellBe ConsultingLisa Marceau
President & FounderAlpha Millenial Health LLCAriel Kramer
President & FounderKlover CommunicationsValerie Palmieri
CEOMOMENTUM ConsultingRachel Braun Scherl
Business Builder, Marketing Strategist, VagipreneurSPARK Solutions for GrowthMaryon Stewart BEM
CEO and FounderFemmar HealthIvana Munci-Vasic
CEO & FounderVitra LabsErkeda DeRouen
CEO & Principal ConsultantDigital Risk Compliance SolutionsBrianna Brennan
Chief Innovation OfficerOntrak HealthClaire Gill
CEOBone Health & Osteoporosis FoundationEmilė Radyte
Co-Founder & CEOSamphire NeuroscienceMira Kaufman
Investment TeamIngeborg InvestmentRachel Robinson
Chief Operating OfficerMassMedicSaranya Loehrer MD, MPH
Chief Health Equity OfficerTeldoc HealthTamika Lane, MSN, RN, CCM
Director, Clinical Innovation and Client RelationshipsSentara Health PlansAndrea Olariu
CEOMedicines360Cory Warner
Global Head of Customer Growth and OperationsUber HealthLucy Perez
PhD, Senior PrincipalMcKinsey & CompanyLucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
Anula Jayasuriya
Co-FounderKidron CapitalMadison Soucie
CEO & FounderJoy LLCZeynep Sabah Bagwell
Head of Personal Care42 TechnologyTracy Warren
ManagerHealthwormx VenturesSarah Knight
Head of Healthcare Technology42 TechnologySabrina Martucci Johnson
President and CEODARÉ BioscienceSabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.
Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.
Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.
Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International.
Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre. She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum.
Lyn Falconio
Board MemberNAYA BiosciencesJennifer Lahey
Talent Optimization ConsultantPredictive Success CorporationFlavia Mason
Global Vice President, Women's HealthPerrigoEva Temkin
Former FDA Counsel and Acting Director for PolicyFDA Office of Therapeutic BiologicsJenica Patterson
DirectorARPA-HRenee Wegryzn
Inaugural DirectorAPRA-H